Black Box Warnings Do Not Make Fluoroquinolone Acceptable
Numerous patients across the United States faced injuries that changed their lives after they used a commonly prescribed antibiotic from the fluoroquinolone drug class. These cases grow with each day, despite there is a series of Black Box Warnings.
FDA recently warned (in March 2018) physicians to avoid prescribing this drug, due to uncomplicated infections including acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and uncomplicated urinary tract infections.
These antibiotics are strong and were used to treat bronchitis, urinary tract infections, diverticulitis, and sinusitis and were widely used because they are taken orally.
Back in 2008, the FDA issued the first black box warning regarding the fluoroquinolone drug class and it was addressed to risks for tendinitis and tendon rupture. In 2013 there was another black box that linked to the potential for irreversible nerve damage.
Three years later, in 2016, there was a new warning for potential permanent side effects to the central nervous system, peripheral nerves, muscles, and tendons.
Which each Black Box Warning your doctor has a legal obligation to warn you of the potential complications if you use this drug.
If your doctor fails to warn you and you get any side effect as described by the Black Box Warning you have a basis for a lawsuit.
Starting from August 2017, Bayer Healthcare Pharmaceutica Inc, Merck & Co Inc., Johnson & Johnson, Janssen Research & Developement LLC have faced 755 fluoroquinolone lawsuits.
The antibiotics categorized as fluoroquinolones are Cipro, Levaquin and Avelox are the ones that did not sufficient warnings and cause certain side effects.
If you have been using any of these antibiotics and did not get a warning from your doctor, and experienced any side effects, you have the right to seek legal help.
Contact us at hurt.com and find an attorney close to you.
Pfizer Inc Files Petition Against Indian Company Aurobindo Pharma Ltd Over Cancer Drug Ibrance
Are Manual Transmissions Making a Comeback?